Rituximab/COVID-19-vaccine Gamaleya National Research Center of Epidemiology and Microbiology: Hemiplegia, ataxia and poor immunisation: case report

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532390/
http://dx.doi.org/10.1007/s40278-021-04437-z
_version_ 1784587057139548160
collection PubMed
description
format Online
Article
Text
id pubmed-8532390
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-85323902021-10-22 Rituximab/COVID-19-vaccine Gamaleya National Research Center of Epidemiology and Microbiology: Hemiplegia, ataxia and poor immunisation: case report Reactions Weekly Case Report Springer International Publishing 2021-10-23 2021 /pmc/articles/PMC8532390/ http://dx.doi.org/10.1007/s40278-021-04437-z Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report
Rituximab/COVID-19-vaccine Gamaleya National Research Center of Epidemiology and Microbiology: Hemiplegia, ataxia and poor immunisation: case report
title Rituximab/COVID-19-vaccine Gamaleya National Research Center of Epidemiology and Microbiology: Hemiplegia, ataxia and poor immunisation: case report
title_full Rituximab/COVID-19-vaccine Gamaleya National Research Center of Epidemiology and Microbiology: Hemiplegia, ataxia and poor immunisation: case report
title_fullStr Rituximab/COVID-19-vaccine Gamaleya National Research Center of Epidemiology and Microbiology: Hemiplegia, ataxia and poor immunisation: case report
title_full_unstemmed Rituximab/COVID-19-vaccine Gamaleya National Research Center of Epidemiology and Microbiology: Hemiplegia, ataxia and poor immunisation: case report
title_short Rituximab/COVID-19-vaccine Gamaleya National Research Center of Epidemiology and Microbiology: Hemiplegia, ataxia and poor immunisation: case report
title_sort rituximab/covid-19-vaccine gamaleya national research center of epidemiology and microbiology: hemiplegia, ataxia and poor immunisation: case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532390/
http://dx.doi.org/10.1007/s40278-021-04437-z

Ejemplares similares